期刊名称：CLINICAL MICROBIOLOGY AND INFECTION
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Clinical Microbiology and Infection (CMI) is a monthly publication in English of the European Society of Clinical Microbiology and Infectious Diseases and publishes peer-reviewed papers that present basic and applied research relevant to therapy and diagnostics in the fields of microbiology, infectious diseases, virology, parasitology, immunology and epidemiology.
Instructions to Authors
Guidelines for Authors
Clinical Microbiology and Infection (CMI) is the official monthly publication of the European Society of Clinical Microbiology and Infectious Diseases. Manuscripts that present the results of original basic and applied research in the fields of clinical microbiology, infectious disease, virology, parasitology, immunology and epidemiology are invited. All submissions are peer-reviewed before a decision on publication is reached. The Editor-in-Chief's decision is final.
Submissions
Please see http://cmi.manuscriptcentral.com for online submission instructions.
Begin with create a new account. Enter personal details and create user ID and password; then go to author centre and proceed as directed.
In case of difficulty, please contact Judith Crane (judith.crane@escmid.org).
Submission Document
Each on-line submission must be followed by a document signed by all named authors.
The document must affirm that all authors have read and agreed to the submitted version of the manuscript, that all those listed in the Acknowledgement section have agreed to their inclusion, and that the manuscript or a significant part of it has not been published or submitted for publication elsewhere. Any previously published material or illustration must be accompanied by the written permission of the copyright holder. Any commercial affiliations should be disclosed in the submission document. Please return this document by post to:
Judith Crane, CMI Editorial Office, 39 Quai de Grenelle, 75015 Paris, France.
Authorship
Anyone named as an author should have made a significant contribution to the overall design of the study or the execution of the work described. CMI considers all authors to be responsible for the content of the entire paper. Individuals who simply provided assistance, e.g., supplied facilities, strains or reagents, or who critiqued the paper, should not be listed as authors, but may be recognised in the Acknowledgement section.
Acknowledgement/Disclosure
All results presented previously at a scientific meeting or in another public context must
be acknowledged, giving the context, location and date of presentation. Acknowledged individuals must be named in full. Sources of funding, as well as a general statement disclosing any degree of commercial or potential dual interest, should be included in the Acknowledgements section.
Manuscript Categories
Editorial:
1000 words maximum; up to 20 references; unstructured abstract up to 100 words.
Review:
5000 words maximum; comprehensive references; 5-10 key words; unstructured abstract up to 250 words.
Original Article:
5000 words maximum; comprehensive references; 5-10 key words; unstructured abstract up to 250 words.
Note:
1000 words maximum, up to 20 references; unstructured abstract up to 100 words; no sub-headings; maximum 1-2 illustrations or tables.
Correspondence:
Letters to the Editor must refer to material published recently in CMI.
A manuscript category may change before publication during the course of revision.
Title Page
All submissions in all categories must include a title page indicating the intended category, the title, the full names and institutional affiliations of each author. Please include a running title of up to 55 characters and spaces. A corresponding author must be named, including
a complete postal address, international telephone and fax numbers and e-mail address.
Text
Manuscripts must be submitted in English (with UK spellings). Authors unsure of English usage should have their manuscripts checked by someone proficient in the English language. Poor English or lack of conformity to accepted CMI standards of style will delay the processing of your submission.
Brevity is an advantage. Do not repeat text in more than one section; do not include text that is redundant with tables or figures. SI units should be used whenever appropriate. Genus and species names should be written in italic in full on first mention. The genus name should then be abbreviated on subsequent mention, provided that no ambiguity will arise. Only generic names of drugs should be used, although trade names may follow in parentheses if necessary for comprehension. Suppliers of specific instruments or compounds should be noted in parentheses, providing both the company name and location.
Abbreviations
Abbreviations and jargon are discouraged, but SI units should be abbreviated throughout. The following common abbreviations can also be used without definition: DNA, cDNA, RNA, cRNA, Rnase, Dnase, rRNA, mRNA, tRNA, AMP, ADP, ATP, dAMP, ddATP, GTP (etc.), NAD, NADH, NADP, NADPH, poly(a), poly(dT) (etc.), oligo(dT) (etc.), UV, PFU, CFU, MIC, Tris, DEAE, EDTA, EGTA, HEPES, PCR, AIDS, IgA, IgG, IgM, abbreviations for cell lines (e.g. HeLa). Other abbreviations should be used only if mentioned three or more times in the text, and should always be written in full on first mention.
Illustrations and Figures
Illustrations should be kept to a minimum. Due to constraints of space, papers with a modest number of illustrations will be given priority for publication. Data reported in tables or figures should not be repeated in the text. Figures should be submitted electronically with the text file whenever possible. Please save artwork as EPS files and bitmat files as TIFF. Ideally, vector graphics that have been saved in metafile (.WMF) or pict (.PCT) format should be embedded within the body of the text file. Please avoid using tints. Detailed information on our digital illustration standards is available at http://www.blackwell-science.com/elecmed/digill.htm. Hard copy of all figures must be prepared and retained by the authors in case it is needed during the publication process. Hard copy should be professionally prepared in the form of high-quality photographic prints (not less than or 13 ¡Á 18 cm) or electronically produced laser prints on A4 bonded paper. There will be a publisher's charge for colour illustrations.
All descriptive or explanatory captions should be typed double-spaced on a separate page following text and tables, and should include full explanations of any abbreviations used in the figure. In the full-text online edition of the journal, figure legends may be truncated in abbreviated links to the full screen version. Therefore the first 100 characters of any legend should inform the reader of key aspects of the figure.
Tables
Each table should be presented on a separate page in the smallest format possible, with
a descriptive or explanatory title, and numbered (using arabic, not roman, numerals) consecutively as cited in the text. Wherever possible tables should be typed as text, using 'tabs' to align columns. The use of table editors should be avoided, as should graphics software to create tables. Please do not use paragraph returns within tables to indicate spacing within blocks of text; use instead a soft return (shift, return). Abbreviations may be used, but must be explained in full as footnotes. Units of measurement must be clearly indicated.
Ethical Considerations
Failure to adhere to ethical requirements and/or inappropriate or unjustified experiments may be considered sufficient reason for rejection of a manuscript. Reports of biomedical research involving human subjects must include a statement in the Methods section that informed consent was obtained, as well as a statement of approval by a local human investigations committee that the research was carried out in accordance with the Helsinki Declaration. Similarly, experiments involving animals must avoid distress to the animals and must have been conducted under appropriate licensing/approval arrangements, details of which should be included in the Methods section.
References
The author is responsible for the accuracy and completeness of all references, which should be numbered sequentially and not alphabetically, with the numbers cited in the text in square brackets before punctuation marks, according to the Vancouver style (examples following).
Article
Henriques Normark B, Normark, S. Antibiotic tolerance in pneumococci. Clin Microbiol Infect 2002; 8: 613-22.
Article from a Supplement
Nikaido H. Crossing the envelope: how cephalosporins reach their targets. Clin Microbiol Infect 2000; 6 (suppl): 22-6.
Book
Finch RG, Greenwood D, Norrby SR, Whitley RJ, eds. Antibiotic and Chemotherapy. 8th edn. Philadelphia: Churchill Livingston, 2003.
Chapter from a Book
Anaerobic bacteria. In: Y VL, Weber R, Raoult D, eds. Antimicrobial Therapy and Vaccines. 2nd edn. New York: Apple Tree Productions, 2002: 55-63.
Published Meeting Abstract
Vukovik Z, Dimitrijevic D. Immunization safety C Serbian experience evaluation [abstract P1117]. In: Abstracts of the 13th European Congress of Clinical Microbiology and Infectious Diseases, Glasgow, UK: European Society of Clinical Microbiology and Infectious Diseases, 2003: 262.
Website
World Health Organization. Global Strategy for the Containment of Antimicrobial Resistance. Geneva: World Health Organization, 2001 [http://www.who.International].
Copies of manuscripts cited as in pres or submitted should be uploaded to the CMI website with the submission to facilitate the review process.
Editorial Board
Editor
Professor Emilio Bouza
CMI Editorial Office
C/Rocinante, No 5 (3oA)
28034 Madrid
Spain
Tel: +34 91 735 54 34
Fax: +34 91 735 54 46
Editorial Office
Judith Crane
CMI Editorial Office
39 Quai de Grenelle
75015 Paris
France
e-mail: cmi@escmid.org
| 
刊名字顺( Alphabetical List of Journals):
返回页首 